SCHOTT Nexterion Takes Over the Microarrays Business Division of Quantifoil Micro Tools
The microarray product range of Quantifoil Micro Tools will now be supplied under the Schott Nexterion umbrella. The decisive factors for the Mainz company in undertaking the acquisition were Qauntifoil Micro Tools' innovative product range and their convincing product quality. Therefore, no changes to the product specifications are planned. Through the integration of the product range into its own product portfolio SCHOTT Nexterion successfully strengthens its position as a supplier of high-quality microarray solutions.
"We are very pleased that along with the attractive product range of Quantifoil Micro Tools, we have also been able to retain their young, dynamic and innovative team. Our existing product portfolio is ideally supplemented by the merger," explained Dr. Dirk van den Broek, member of the Management Board, SCHOTT Nexterion AG.
With this merger, SCHOTT Nexterion is consistently implementing its strategy for expanding its product portfolio. The company develops slides and coatings for DNA microarrays and has already launched a product on the market: Nexterion Slide A, which facilitates a higher sensitivity when undertaking microarray experiments. SCHOTT Nexterion will continue to work earnestly at making new developments and breakthroughs, such as current projects that include a coated slide for protein applications and multiplex slides.
Janko Otto, CEO of Quantifoil Micro Tools GmbH, made the following comment regarding the merger: "By using the worldwide sales network of the SCHOTT Group we can better market our products which have already been successfully launched. In addition, the access to the resources of the multinational, technology-based SCHOTT Group will provide us with invaluable support in the development of new products."
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.